Abstract
The pharmacological treatment of the elderly patient represents a therapeutic problem which, over the last decade, has reached a totally unexpected dimension with important social, medical and economic implications [1,2]. A better understanding of various aetiopathogenic factors and the improvement of therapeutic possibilities are factors which have contributed to a better quality of life and an increase in life expectancy. However, at the same time there has been an increase in the ‘institutionalization’ of the elderly, as well as in the use of agents capable not only of curing illnesses but also of modifying behaviour in ways not always acceptable to the family and/or the community.
Preview
Unable to display preview. Download preview PDF.
Reference
World Health Organization. Health care in the elderly: report of the technical group on use of medicaments by the elderly. Drugs 1981; 22: 279–94.
Royal College of Physicians. Medication for the elderly. J R Coll Physicians Lond 1984; 18: 3–10.
Grundy, E. Demography and old age. J Am Geriatr Soc 1984; 31: 325–32.
Butler, R. N. A changing demography. In: Butler R. N., Bearn, A. G., eds. The Ageing Process: Therapeutic Implications. New York: Raven Press, 1984; 5–18.
Haavisto, M., Geiger, U., Mattila, K., Rajala, S. A health survey of the very aged in Tampere, Finland. Age Ageing 1984; 13: 266–72.
Grundy, E., Arie, T. Institutionalization and the elderly: International comparisons. Age Ageing 1984; 13: 129–37.
Jefferys, M. The elderly in society. In: Brocklehurst, J. C., ed. Textbook of Geriatric Medicine and Gerontology, Edinburgh: Churchill Livingstone, 1978; 763–82.
Insee. Recensement général de la population. Structure de la population totale. Insee, 1985; Série D, No 98.
Hale, W. E., Perkins, L. L., May, F. E., Marks, R. G. et al. Symptom prevalence in the elderly. An evaluation of age, sex, disease, and medication use. J Am Geriatr Soc 1986; 34: 333–40.
Kivelä, S. L. Disability among home-nursed patients and home-help clients. Scand J Soc Med 1985; 13: 75–82.
Magni, G., Shifano, F., de Leo, D. Assessment of depression in an elderly medical population. J Affective Disord 1986; 11: 121–4.
Ravizza, L. Diagnostic and therapeutic problems in the psychopharmacological treatment of the elderly patient. Neuropsychobiology 1986; 15: 15–8.
Brooks, P. M., Kean, W. F., Kassam, Y., Buchanan, W. W. Problems of antiarthritic therapy in the elderly. J Am Geriatr Soc 1984; 32: 229–34.
Lamy, P. P. Renal effects of nonsteroidal anti-inflammatory drugs. Heightened risk to the elderly? J Am Geriatr Soc 1986; 34: 361–7.
Patterson, C. Iatrogenic disease in late life. Clinics in Geriatric Medicine 1986; 2: 121–36.
Moir, D. C., Dingwall-Fordyce, I. Drug taking in the elderly at home. J Clin Exptl Gerontol 1980; 2: 329–12.
Lamy, P. P. Patterns of prescribing and drug use. In: Butler, R. N., Bearn, A. G., eds. The Ageing Process: Therapeutic Implications, New York: Raven Press, 1984; 53–82.
Salzman, C. Polypharmacy and drug interaction in the elderly. In: Nandy, ed. Geriatric Psychopharmacology, North Holland: Elsevier, 117–26.
Black, D. Medication for the elderly. In: Butler, R. N., Bearn, A. G., eds. The Aging Process: Therapeutic Implications, New York: Raven Press, 1984; 299–305.
Shimp, L. A., Ascione, F. J., Glazer, H. M., Atwood, B. F. Potential medication-related problems in noninstitutionalized elderly. Drug Intell Clin Pharm 1985; 19: 766–72.
Williamson, J., Chopin, J. M. Adverse reactions to prescribed drugs in the elderly: a multicentre investigation. Age Ageing 1980; 9: 73–80.
Davison. W. Adverse drug reactions in the elderly: general considerations. In: Butler, R. N. and Bearn, A. G., eds. The Aging Process: Therapeutic Implications, New York: Raven Press, 1984; 101–11.
Alexander, R. N., Godwin, J. S., Carrie, C. Comparison of admission and discharge medications in two geriatric populations. J Am Geriatr Soc 1985; 32: 827–32.
Freer, C. B. Study of medicine prescribing for elderly patients. Br Med J 1985; 292: 1113–5.
Shapiro, S., Avery, K. T., Carpenter, R. D. Drug utilization by a non-institutionalized ambulatory elderly population. Gerontology 1986; 2: 99–103.
Hurtwitz, N. Predisposing factors in adverse reactions to drugs. Br Med J 1969; 1: 536–9.
Décamps, A., Dumas, R., Dordain, G., Lavarenne, J. Accidents neuropsychiques d’origine médicamenteuse chez les sujets âgés. Thérapie 1984; 39: 39–46.
Klein, U., Klein, M., Sturm, H. Rothenbühler M., et al. The frequency of adverse drug reactions as dependent upon age, sex and duration of hospitalization. Int J Clin Pharmacol 1976; 13: 187–95.
Pickels, H. Prescriptions, adverse reactions and the elderly. Lancet 1986; 8497: 40–1.
Kelsey, F. O. Investigational new drug trials in geriatric subjects. In: Moore, S. Q., Teal, T. W., eds. Geriatric Drug Use—Clinical and Social Perspectives, New York: Pergamon Press, 1985; 177–81.
Temple, R. Guidelines for studying drugs in the elderly. In: Moore, S. R., Teal, T. W., eds. Geriatric Drug Use. Clinical and Social Perspectives, Oxford: Pergamon Press, 1985; 171–6.
Morgan, B. D., Newton, H. M. V., Schorah, C. J., Jewitt, M. A. et al. Abnormal indices of nutrition in the elderly: a study of different clinical groups. Age Ageing 1986; 15: 65–76.
Lindeman, R. D., Tobin, J., Shock, N. W. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985; 33: 278–85.
Rodeheffer, R. J., Gerstenblith, G., Becker, L. C., Fleg, J. L. et al. Exercise cardiac output is maintained with advancing age in healthy human subjects: cardiac dilatation and increased stroke volume compensate for a diminished heart rate. Circulation 1984; 69: 203–13.
Williams, M. E. Clinical implications of aging physiology. Am J Med 1984; 76: 1049–54.
Docherty, J. R. Aging and the cardiovascular system. J Auton Pharmacol 1986; 6: 77–84.
Brockelhurst, J. C. Aging in the autonomic nervous system. Age Ageing 1975; 4: 7–14.
Pack, A. I., Millman, R. P. Changes in control of ventilation, awake and asleep, in the elderly. J Am Geriatr Soc 1986; 34: 533–4.
Westenend, M., Lenders, J., Thien T. The course of blood pressure after a meal: a difference between young and elderly subjects. J Hypertens 1985; 3: S417–9.
Fagan, T., Conrad, K. A., Mar, J. H., Nelson, L. Effects of meals on hemodynamics: implications for antihypertensive drug studies. Clin Pharmacol Ther 1986; 39: 255–60.
Zarit, S. H., Gallagher, D., Kramer, N. Memory training in the community aged: effects on depression, memory complaint, and memory performance. Educational gerontology, an international quarterly 1981; 6: 11–27.
Rowe, J. W. Physiologic changes with age and their clinical relevance. In: Butler, R. N., Bearn, A. G., eds. The Aging Process: Therapeutic Implications, New York, Raven Press, 1984; 41–52.
O’Malley, K., Tudge, T. G., Crooks, J. Geriatric clinical pharmacology and therapeutics. In: Avery, ed. Drug Treatment, Sydney: Adis Press, 1976; 123–42.
Morselli, P. L., Placidi, G. F. Terapia farmacologica nel soggetto anziano: aspetti farmacocinetici. In: Muratrio, A., Maggini, C., Muni, L. eds. Il sonno nell’età senile, Pisa: Pacini Editore, 1977; 161–74.
Greenblatt, D. J., Abernethy, D.R., Shader, R. I. Pharmacokinetic aspects of drug therapy in the elderly. Ther Drug Monit 1986; 8: 249–55.
Guillet, P., Piette, F. Pharmacologie du sujet âgé. Rev Prat 1986; 36: 581–92.
Vestal, R. E., Wood, A. J. J., Shand, D. G. Reduced beta-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther 1979; 26: 181–6.
Dillon, N., Chung, S., Kelly, J., O’Malley, K. Age and beta-adrenoceptor mediated function. Clin Pharmacol Ther 1980; 27: 769–72.
Castleden, C. M., George, C. F., Marcer, D., Hallett, C. Increased sensitivity to nitrazepam in old age. Br Med J 1977; 1: 10–2.
Pomara, N., Stanley, B., Block, R. et al. Adverse effects of single therapeutic doses of diazepam on performance in normal geriatric subjects: relationship to plasma concentrations. Psychopharmacology 1984; 84: 342–6.
Moskowitz, H., Burns, M. M. Cognitive performance in geriatric subjects after acute treatment with antidepressants. Neuropsychobiology 1986; 15: 38–43.
Riecken, H. W., Ravich, R. Informed consent to biomedical research in veterans administration hospitals. JAMA 1982; 248: 344–8.
Stanley, B., Guido, J., Stanley, M., Shortell, D. The elderly patient and informed consent. Empirical findings. JAMA 1984; 252: 1302–6.
Denham, M. J. The ethics of research in the elderly. Age Ageing 1984; 13: 321–7.
Berry, G., Fisher, R. H., Lang, S. Detrimental incidents, including falls in elderly institutional population. J Am Geriatr Soc 1981; 29(7): 322–4.
Perri, B. C. Falls among the elderly: a review of the methods and conclusions of epidemiologic studies. J Am Geriatr Soc 1982; 30: 367–71.
Leader, M. A., Neuwirth, E. Clinical research and the noninstitutional elderly: a model for subject recruitment. J Am Geriatr Soc 1978; 26: 27–31.
Sheiner, L. B., Benet, L. Z. Premarketing observational studies of population pharmacokinetics of new drugs. Clin Pharmacol Ther 1985; 38: 481–7.
Editor information
Editors and Affiliations
Copyright information
© 1988 The International Federation of Associations of Pharmaceutical Physicians
About this chapter
Cite this chapter
Morselli, P.L., Guillet, P. (1988). Drug development in the elderly: problems and constraints. In: Burley, D., Haward, C., Mullinger, B. (eds) The Focus for Pharmaceutical Knowledge. Palgrave, London. https://doi.org/10.1007/978-1-349-09571-1_27
Download citation
DOI: https://doi.org/10.1007/978-1-349-09571-1_27
Publisher Name: Palgrave, London
Print ISBN: 978-1-349-09573-5
Online ISBN: 978-1-349-09571-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)